{"url":"https://lda.gov/api/v1/filings/a6d2d871-1f27-4607-8648-bce29743913d/?format=json","filing_uuid":"a6d2d871-1f27-4607-8648-bce29743913d","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a6d2d871-1f27-4607-8648-bce29743913d/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeffrey Gruenglas","dt_posted":"2026-08-26T14:18:35-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"44 Nyes Neck Road","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Centerville","registrant_state":"MA","registrant_zip":"02632","registrant":{"id":401110911,"url":"https://lda.gov/api/v1/registrants/401110911/?format=json","house_registrant_id":null,"name":"NEW ENGLAND RESEARCH GROUP","description":null,"address_1":"44 Nyes Neck Road","address_2":null,"address_3":null,"address_4":null,"city":"Centerville","state":"MA","state_display":"Massachusetts","zip":"02632","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY GRUENGLAS","contact_telephone":"+1 917-692-3110","dt_updated":"2026-07-28T12:58:36.572473-04:00"},"client":{"id":74718,"url":"https://lda.gov/api/v1/clients/74718/?format=json","client_id":74718,"name":"NEW ENGLAND RESEARCH GROUP","general_description":"Health Policy Consulting","client_government_entity":null,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Drug access, reimbursement, patient advocacy","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155036,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"GRUENGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}